Acute Coronary Syndrome: all 1,492 studies

Page 13 of 15. Open to participants first (270), then studies with results posted, then the rest; newest registration first within each.

• Peking and Rotterdam on Mission to Reduce Coronary Artery DiseaseStatus unknownNCT01653119Not applicable
• Phase I Study of GW856553 (Losmapimod)CompletedNCT01648192Phase 1
• Invasive vs Conservative Strategies in Non-ST-elevation Acute Coronary Syndrome and ComorbiditiesCompletedNCT01645943Phase 4
• Telemedical Support in Prehospital Emergency Care of Acute Coronary SyndromeCompletedNCT01644006Not applicable
• Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionCompletedNCT01642966Phase 4
• Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic StudyCompletedNCT01642940Phase 4
• Portuguese Registry on Acute Coronary SyndromesStatus unknownNCT01642329
• PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic VariantsCompletedNCT01641510Phase 3
• STEMI Versus NSTEMI: Clinical and Angiographic DifferencesCompletedNCT01636427
• SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)CompletedNCT01636271
• Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4CompletedNCT01632371Phase 4
• Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary SyndromeCompletedNCT01626534Phase 3
• Outcome of Longterm Antithrombotic Therapy in Acute Coronary Syndrome PatientsStatus unknownNCT01623700
• Tryptase and Coronary Heart DiseaseCompletedNCT01618279
• A Post Marketing Surveillance to Evaluate the Safety and Efficacy of BrilintaCompletedNCT01611272
• Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary InterventionCompletedNCT01609647Phase 3
• ProspEctive First Evaluation in Chest Pain TrialCompletedNCT01604655Not applicable
• Endothelial Dysfunction and Plaque VulnerabilityCompletedNCT01578616
• IVUS Assessment of Atheroma Burden After Acute Coronary SyndromeCompletedNCT01578005
• Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel TherapyStatus unknownNCT01572129Phase 4
• Improving the Management of Acute Coronary Syndromes in the Emergency DepartmentCompletedNCT01563250Phase 4
• The Supplementary Role of Non-invasive Imaging to Routine Clinical Practice in Suspected Non-ST-elevation Myocardial InfarctionCompletedNCT01559467Not applicable
• PET/CT for the Quantification of Atherosclerotic Plaque InflammationStatus unknownNCT01553513
• Tailored Antiplatelet Therapy Versus Recommended Dose of PrasugrelCompletedNCT01538446Phase 4
• Controlled Level EVERolimus in Acute Coronary SyndromesCompletedNCT01529554Phase 1/2
• Shared Care Rehabilitation After Acute Coronary SyndromeCompletedNCT01522001Phase 4
• TAKO-TSUBO Cardiomyopathy and GeneticCompletedNCT01520610
• Genetic Mapping for Cardiac Risk AssessmentStatus unknownNCT01506999
• Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary InterventionCompletedNCT01505790Phase 3
• Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)TerminatedNCT01504945Phase 1/2
• Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting StentsCompletedNCT01502904Phase 4
• Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary SyndromeCompletedNCT01500902Not applicable
• Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)CompletedNCT01498731Not applicable
• Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch BlockStatus unknownNCT01494870Not applicable
• Prasugrel Versus Clopidogrel to TREAT High Platelet ReactivityCompletedNCT01493999Phase 4
• Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin LoadingStatus unknownNCT01491256Not applicable
• A NIS Registry of the Prospective Structured Care In Acute Coronary SyndromeCompletedNCT01490645
• Customized Choice of Oral P2Y12 Receptor BlockerStatus unknownNCT01477775Phase 4
• Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE TrialCompletedNCT01465828Phase 3
• Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)CompletedNCT01460966Not applicable
• Allopurinol in Acute Coronary SyndromeTerminatedNCT01457820Phase 4
• Ankle-Brachial Index Estimating Cardiac Complications After SurgeryCompletedNCT01452282
• Statins Evaluation in Coronary Procedures and Revascularization TrialCompletedNCT01448642Phase 4
• Imaging Whole Coronary Artery With Intravascular Ultrasound (Ivus) And Imap For Plaque Tissue Composition In Patients With Acute Myocardial InfarctionCompletedNCT01437553Not applicable
• Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioXStatus unknownNCT01433627Phase 3
• Comparative Pharmacokinetics of YH14659CompletedNCT01422109Phase 1
• RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary SyndromeStatus unknownNCT01420614Not applicable
• Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery DiseaseStatus unknownNCT01418794Phase 4
• Better Evaluation of Acute Chest Pain With Computed Tomography AngiographyCompletedNCT01413282Not applicable
• African-American PharmacogeneticsStatus unknownNCT01408121
• Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral StudyCompletedNCT01407146
• Fondaparinux EU-RMP (Adherence)CompletedNCT01406301
• Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCTCompletedNCT01405287Phase 2
• A Comparison of the TIMI, GRACE and HEART ScoresCompletedNCT01398631
• Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3CompletedNCT01398228Not applicable
• OPTImal CArdiac REhabilitation (OPTICARE) Following Acute Coronary SyndromesCompletedNCT01395095Not applicable
• Vascular Healing of DES at 3 MonthsCompletedNCT01391871
• Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary SyndromeCompletedNCT01390974
• Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary SyndromeCompletedNCT01384656Phase 4
• Microcirculation In Acute Coronary SyndromesCompletedNCT01382472Phase 4
• Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia DetectionCompletedNCT01374607
• Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in RussiaCompletedNCT01373957
• Intensive Statin Therapy in PCI Patient With Acute Coronary SyndromeStatus unknownNCT01372839Phase 4
• Assessment of Biomarkers for Diagnosis in Geriatric PatientsStatus unknownNCT01370395
• Comparison Between the New Highly Sensitive Troponin T and the Conventional Troponin T Test in Elderly PatientsCompletedNCT01370382
• Clearance Of Mucus In Stents (COMIS)CompletedNCT01370278Not applicable
• The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of ClopidogrelCompletedNCT01365221Phase 4
• Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in AsiaCompletedNCT01361386
• Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary InterventionCompletedNCT01360437Phase 3
• A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)CompletedNCT01358344Phase 1
• Patients With High-risk Acute Coronary Syndrome Without ST-segment ElevationTerminatedNCT01356992Phase 3
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial FibrillationTerminatedNCT01352702Phase 4
• Effectiveness of Thrombus Aspiration in Plaque Reduction for Patients With Acute Coronary SyndromesCompletedNCT01342848
• Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary InterventionTerminatedNCT01339026Phase 4
• Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA)CompletedNCT01335087Not applicable
• Copeptin and Acute Coronary Syndrome Without ST-segment ElevationCompletedNCT01334645Not applicable
• DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers PopulationCompletedNCT01331707Phase 4
• Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's WortWithdrawnNCT01330589Not applicable
• Effect of Air Pollution in the Haifa Bay Area on Cardiovascular Morbidity and MortalityStatus unknownNCT01325155
• Prediction of Progression of Coronary Artery Disease (CAD) Using Vascular Profiling of Shear Stress and Wall MorphologyStatus unknownNCT01316159
• Experience in Predicting Decision Making for Receiving Treatment in Acute Coronary Syndrome PatientsCompletedNCT01313338
• AMIS Plus - National Registry of Acute Myocardial Infarction in SwitzerlandStatus unknownNCT01305785
• Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) PatientsCompletedNCT01280630
• Function of High Density Lipoproteins in Acute Coronary SyndromesActive, not recruitingNCT01278875
• Trial of Screening for ALOA-IgG AtheroAbzyme TestCompletedNCT01272986Phase 3
• The Efficacy and Safety of Anticoagulation in Chinese Patients With Non-ST Segment Elevation Acute Coronary SyndromeStatus unknownNCT01271101
• Mind-body Interventions in Cardiac PatientsCompletedNCT01270568Not applicable
• Using IVR to Maintain ACS Patients on Best Practice GuidelinesTerminatedNCT01260207Phase 3
• The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome PatientsStatus unknownNCT01255267
• Stent For Life ObservatoryCompletedNCT01251198
• Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACSStatus unknownNCT01245803Phase 4
• Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary InterventionWithdrawnNCT01245725Phase 3
• Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography StudyCompletedNCT01239654Phase 3
• French Registry of Acute Coronary Syndrome With or Without ST Elevation 2010CompletedNCT01237418
• Hepatocyte Growth Factor (HGF) Concentration in Myocardial InfarctionCompletedNCT01233336
• Cohort Study of Clopidogrel and Proton Pump InhibitorsCompletedNCT01231867
• Study to Develop a Non-invasive Marker for Monitoring Myocardial FibrosisTerminatedNCT01230918Phase 2
• Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary SyndromeCompletedNCT01223586
• Registry of Acute Coronary Syndromes in the Lazio Region of ItalyStatus unknownNCT01216462
• Secondary Prevention of coRonary Events After Discharge From Hospital (SPREAD)CompletedNCT01207700Not applicable

← Acute Coronary Syndrome overview